UnknownNot Applicable

Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.

Italy900 participantsStarted 1993-03

Plain-language summary

The aim of this study is to estimate the incidence of spontaneous and provoked recurrent VTE and the bleeding events during a 10-year follow-up in subjects experiencing a first VTE stratified according to % AT levels and to treatment schedule (long-term vs 6-12 months oral anticoagulation+transient prophylaxis during high risk periods)

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Recent (\<3 months) First VTE event Exclusion Criteria: * missing data during the follow-up; contraindications to or lack of compliance to oral anticoagulation (OAT), lack of informed consent; history of previous VTE event; indication for continuous oral anticoagulation (e.g., an artificial heart valve or chronic atrial fibrillation); events occurring during pregnancy, malignancy, puerperium, oral contraceptive intake, hormone replacement therapy; deficiencies of Prot. C and Prot S or combined inhibitor deficiencies.

What they're measuring

VTE recurrence during the 8-year follow-up

Timeframe: At an average of 8 years of follow-up

Trial details

NCT IDNCT01382550

SponsorFederico II University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-09

Contact for this trial

Giovanni Di Minno, Prof

+390817462060 diminno@unina.it

View on ClinicalTrials.gov More Venous Thrombosis trials